Introduction: the rationale for the development of targeted drugs in cancer therapy.
Groner
Bernd
B
Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt am Main, Germany. groner@em.uni-frankfurt.de
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents